General composition framework for ligand-controlled regulatory systems
The invention provides an improved design for the construction of extensible nucleic acid-based, ligand-controlled regulatory systems, and the nucleic acid regulatory systems resulting therefrom. The invention contemplates improving the ...
Smolke, Christina D，MN Win，Beisel, Chase L - US
PDMDAAC合成工艺、聚合反应机理及结构与性质的关系
聚二甲基二烯丙基氯化铵(简称PDMDAAC)为二甲基二烯丙基氯化铵(简称DMDAAC)的均聚物,是一种典型的阳离子聚电解质,它在造纸,采煤,石油开采,纺织,印染,日用化妆品,水处理...
贾旭 - 《南京理工大学》
Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
The present invention is directed to pharmaceutical compositions comprising prasugrel and a cyclodextrin derivative, and methods of making and using the same.
GL Mosher，SG Machatha，DJ Cushing - US
Nanoparticulate posaconazole formulations
The present invention is directed to pharmaceutical compositions comprising prasugrel and a cyclodextrin derivative, and methods of making and using the same.
The designation of the inventor has not yet been filed
PROCESS FOR PREPARATION OF ANHYDROUS AZITHROMYCIN
The present invention provides a stable form of azithromycin derivatives that act as antibiotics. These compounds are in anhydrous form and have increased stability over the hydrated forms.
SP Singh，SM Jaweed Mukarram，M Purohit，...
Nanoparticulate posaconazole formulations
The invention is directed to compositions comprising a nanoparticulate posaconazole, or a salt or derivative thereof, having improved bioavailability. The nanoparticulate posaconazole particles of the composition have an effective averag...
S Jenkins，G Liversidge - WO
Pharmaceutical compositions of dextran polymer derivatives and a carrier material
Pharmaceutical compositions are provided comprising (a) nanoparticles of an active agent and a dextran polymer derivative, and (b) a carrier material.
DT Friesen，DT Vodak - US
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invent...
H Binch，PDJ Grootenhuis，Sara S. Hadida Ruah，... - US
NANOPARTICULATE KINASE INHIBITOR FORMULATIONS
The invention is directed to compositions comprising at least one nanop articulate kinase inhibitor, such as LS 104 or a salt or derivative thereof, having improved dissolution rate providing a faster onset of drug availability. The nano...
LIVERSIDGE Elaine，CARY Greta，BOSCH William H.，... - WO
Cosmetic and pharmaceutical compositions and their use
Pharmaceutical and cosmetical compositions comprising a chelating and a sequestering agent, and optionally containing further ingredients. Use of such compositions to make water more compatible with the skin. Use of such compositions to ...
E Fernandez-Kleinlein，M Hauser，Otto Von Stetten，... - CA
